INTERSTITIAL LUNG DISEASE
Clinical trials for INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a lung fibrosis drug help COVID-19 survivors breathe easier?
Disease control CompletedThis study tested whether nintedanib, a drug used for lung scarring, could slow lung damage in people who had severe COVID-19 and still had lung problems more than 30 days later. 103 adults who needed oxygen or had low oxygen levels joined the trial. The main goal was to see if t…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated May 17, 2026 00:40 UTC
-
New inhaled therapy shows promise for rare lung complication
Disease control CompletedThis study tested an inhaled drug called treprostinil in 5 people with sarcoidosis who also had high blood pressure in the lungs and lung scarring. The goal was to see if the drug could improve blood flow and exercise ability. The treatment is meant to manage symptoms and slow di…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated May 17, 2026 00:32 UTC
-
Inhaled treprostinil shows promise for exercise in PAH-ILD patients
Disease control CompletedThis study looked at how an inhaled drug called treprostinil affects exercise ability in people with pulmonary hypertension caused by interstitial lung disease. 29 participants took the drug for 3 months. Researchers measured heart function and breathing efficiency during exercis…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for scleroderma patients with worsening lung disease?
Disease control CompletedThis study tested whether adding a strong immune-suppressing drug (cyclophosphamide) to standard steroid treatment (prednisone) could stop or slow lung damage in people with scleroderma-related lung disease. 40 adults with worsening lung function took part. The goal was to see if…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Inhaled drug shows safety in long-term use for rare lung-heart condition
Disease control CompletedThis study checked the long-term safety of an inhaled powder drug (treprostinil palmitil) in 31 people with pulmonary hypertension caused by interstitial lung disease. Participants had already completed a previous study of the same drug. The main goal was to see how many had side…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated May 04, 2026 16:32 UTC
-
New inhaled therapy shows promise in slowing deadly lung disease progression
Disease control CompletedThis study tested whether an inhaled medication called treprostinil could help people with idiopathic pulmonary fibrosis, a progressive lung scarring disease. 598 participants either received the active medication or a placebo inhaler for 52 weeks to see if it could slow the decl…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Apr 06, 2026 14:19 UTC
-
Walking program shows promise for lung disease patients
Symptom relief CompletedThis study looked at whether a supervised exercise program can help people with pulmonary hypertension (high blood pressure in the lungs) become more physically active. About 97 adults aged 21 to 82 took part, with some starting exercise right away and others waiting 10 weeks. Th…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC
-
Simple breathing device shows promise for lung disease fatigue
Symptom relief CompletedThis study tested whether a lung boost exercise device could improve breathing and reduce fatigue in 40 women with interstitial lung disease (ILD). Participants used the device and had their lung function, oxygen levels, and tiredness measured before and after treatment. The goal…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC
-
Stomach hernia may signal early lung scarring, small study suggests
Knowledge-focused CompletedThis study looked at whether a hiatal hernia (a stomach issue) is linked to early, hidden lung damage that could lead to scarring. Researchers compared 14 adults with and without hiatal hernia, measuring stomach fluid in the lungs and blood markers of injury. The goal was to find…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated May 17, 2026 00:30 UTC
-
Ultrasound vs. blood test: which better measures lung severity in ICU?
Knowledge-focused CompletedThis study looked at 86 ICU patients with a lung condition called interstitial syndrome. Researchers compared a lung ultrasound score with a standard blood oxygen test to see if the ultrasound could reliably measure how severe the condition is. They repeated both tests at the sta…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
New app puts chronic disease management in your pocket
Knowledge-focused CompletedThis study checked how easy and acceptable the P-STEP mobile app is for people with chronic conditions like asthma, COPD, heart disease, or type 2 diabetes. 178 adults in Leicester, UK, used the app for 12 weeks. The goal was to see if the app is user-friendly and helpful for man…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: University of Leicester • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC